Modular linker compound for target-binding drug conjugates.

Abstract

The present invention relates to modular linker compounds for target-binding drug conjugates (TBDCs), and in particular to modular linker compounds for antibody-drug conjugates (ADCs). The invention further relates to methods for synthesizing the modular linker compound, to target-binding drug conjugates comprising the modular linker compound of the invention, and to pharmaceutical compositions comprising target-binding drug conjugates of the invention. The embodiments of the invention were developed particularly as target-binding drug conjugates for use in cancer treatment and will be described below with reference to this application. However, it will be appreciated that the invention is not limited to this particular field of use.